237 related articles for article (PubMed ID: 17889852)
1. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies.
Pellett S; Tepp WH; Clancy CM; Borodic GE; Johnson EA
FEBS Lett; 2007 Oct; 581(25):4803-8. PubMed ID: 17889852
[TBL] [Abstract][Full Text] [Related]
2. SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E.
Bak N; Rajagopal S; Stickings P; Sesardic D
Toxins (Basel); 2017 Jul; 9(7):. PubMed ID: 28726719
[TBL] [Abstract][Full Text] [Related]
3. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
4. Progress in cell based assays for botulinum neurotoxin detection.
Pellett S
Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357
[TBL] [Abstract][Full Text] [Related]
5. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
Sharma SK; Ferreira JL; Eblen BS; Whiting RC
Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
[TBL] [Abstract][Full Text] [Related]
6. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Dolimbek BZ; Jankovic J; Atassi MZ
Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B).
Shearer JD; Vassar ML; Swiderski W; Metcalfe K; Niemuth N; Henderson I
Vaccine; 2010 Oct; 28(45):7313-8. PubMed ID: 20816903
[TBL] [Abstract][Full Text] [Related]
8. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
Cai F; Adrion CB; Keller JE
Infect Immun; 2006 Oct; 74(10):5617-24. PubMed ID: 16988237
[TBL] [Abstract][Full Text] [Related]
9. Detection of
Bano L; Tonon E; Drigo I; Pirazzini M; Guolo A; Farina G; Agnoletti F; Montecucco C
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29921757
[TBL] [Abstract][Full Text] [Related]
10. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
[TBL] [Abstract][Full Text] [Related]
11. Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins.
Pellett S; Tepp WH; Johnson EA
Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31817843
[TBL] [Abstract][Full Text] [Related]
12. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B.
Cheng LW; Henderson TD; Lam TI; Stanker LH
Toxins (Basel); 2015 Nov; 7(12):5068-78. PubMed ID: 26633496
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.
Held DM; Shurtleff AC; Fields S; Green C; Fong J; Jones RG; Sesardic D; Buelow R; Burke RL
Clin Vaccine Immunol; 2010 Jun; 17(6):930-6. PubMed ID: 20410329
[TBL] [Abstract][Full Text] [Related]
14. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics.
Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B
Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
Bigalke H; Rummel A
Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat.
Martin V; Carre D; Bilbault H; Oster S; Limana L; Sebal F; Favre-Guilmard C; Kalinichev M; Leveque C; Boulifard V; George C; Lezmi S
Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787077
[TBL] [Abstract][Full Text] [Related]
17. Alternative vaccination against equine botulism (BoNT/C).
Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R
Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309
[TBL] [Abstract][Full Text] [Related]
18. A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.
Rhéaume C; Cai BB; Wang J; Fernández-Salas E; Aoki KR; Francis J; Broide RS
Toxins (Basel); 2015 Jun; 7(7):2354-70. PubMed ID: 26114335
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
Pellett S; Tepp WH; Johnson EA; Sesardic D
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
[TBL] [Abstract][Full Text] [Related]
20. A microscale neuron and Schwann cell coculture model for increasing detection sensitivity of botulinum neurotoxin type A.
Hong WS; Young EW; Tepp WH; Johnson EA; Beebe DJ
Toxicol Sci; 2013 Jul; 134(1):64-72. PubMed ID: 23564642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
